DexTech Medical files a new patent application with the European Patent Office
Dextech has filed a new patent application regarding GMP production (Good Manufacturing Practice) of the company's lead candidate OsteoDex with the European Patent Office (EPO.Org). The application describes a GMP synthesis method on a larger scale that results in a pharmaceutical-grade product as well as OsteoDex use for the treatment of cancer that develops in the bones. The application is of great importance for the Company's planned clinical further development of OsteoDex (phase 3, castration-resistant prostate cancer) together with a major partner. "- A synthesis patent will